Sitravatinib and Tislelizumab in Patients With Metastatic Uveal Melanoma With Liver Metastases.
Clinical trial NCT05542342 · COMPLETED
Trial details
- NCT number
- NCT05542342
- Sponsor
- Grupo Español Multidisciplinar de Melanoma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-23
- Primary completion
- 2023-12-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.